We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IXJ market cap is 4.43B. The company's latest EPS is USD 11.3440 and P/E is 8.84.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 40.67M | 43.29M | 55.12M | 67.16M | 72.04M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 15.78M | 539.56M | 418.8M | -113.07M | 500.84M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.98B | 2.71B | 3.5B | 4.11B | 4.13B |
| Total Liabilities | 34.43M | 6.44M | 7.41M | 30.86M | 21.44M |
| Total Equity | 1.95B | 2.71B | 3.49B | 4.08B | 4.11B |
| Market Cap | 4.43B |
| Price to Earnings Ratio | 8.84 |
| Price to Sales Ratio | 61.47 |
| Price to Cash Ratio | 1.27k |
| Price to Book Ratio | 1.08 |
| Dividend Yield | - |
| Shares Outstanding | 44.15M |
| Average Volume (1 week) | 80.37k |
| Average Volume (1 Month) | 134.26k |
| 52 Week Change | 17.23% |
| 52 Week High | 100.38 |
| 52 Week Low | 77.96 |
| Spread (Intraday) | 6.04 (5.71%) |
| Company Name | iShares Global Healthcare |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ishares.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
